BioNTech Quote on Vaccine Efficacy Against Variants

„The current BN162 (Comirnaty) vaccine can induce antibody formation against the alpha and beta variants under laboratory conditions. No data is available on later variants. There has been no variant adaptation of the vaccine since the start of the vaccination campaign, and no adaptation is planned for the boosters. There is no general recommendation for a booster, and the benefits of vaccination must always be weighed up on an individual basis,“

BioNTechBioNTech explains Comirnaty's effectiveness against alpha and beta variants and the individual benefit assessment for boosters.

Previous Next

BioNTech is a German biotechnology company specializing in the development of immunotherapies, particularly mRNA-based vaccines.

Translation or original: 🇩🇪Click here

Quelle: Hier klicken

i

⭐ Zitat bewerten:

3.0 / 5

BioNTech|conventional medicine, covid1984, doctor, fascism, fear industry, pharmaceutical industry, politics, psychoterror, science, vaccinate, vaccination mobbing

BioNTech SE was founded in 2008 in Mainz, Germany, and gained worldwide recognition for developing one of the first approved mRNA-based COVID-19 vaccines in collaboration with Pfizer. The company researches personalized cancer vaccines and other immunotherapeutic approaches.